{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,26]],"date-time":"2026-02-26T12:47:52Z","timestamp":1772110072013,"version":"3.50.1"},"reference-count":64,"publisher":"Medknow","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2008,7]]},"DOI":"10.1111\/j.1745-7262.2008.00409.x","type":"journal-article","created":{"date-parts":[[2008,6,19]],"date-time":"2008-06-19T02:37:49Z","timestamp":1213843069000},"page":"525-534","source":"Crossref","is-referenced-by-count":36,"title":["Treatment of central precocious puberty by GnRH analogs: long-term outcome in men"],"prefix":"10.4103","volume":"10","author":[{"given":"Silvano","family":"Bertelloni","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dick","family":"Mul","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"2581","reference":[{"key":"10.1111\/j.1745-7262.2008.00409.x-BIB1","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1046\/j.0300-0664.2001.01490.x","article-title":"Management and outcome of central precocious puberty","volume":"56","author":"Partsch","year":"2002","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.1111\/j.1745-7262.2008.00409.x-BIB2","first-page":"1509","volume-title":"Williams Textbook of Endocrinolgy","author":"Grumbach","year":"1998"},{"key":"10.1111\/j.1745-7262.2008.00409.x-BIB3","doi-asserted-by":"crossref","first-page":"1851","DOI":"10.1517\/13543784.16.11.1851","article-title":"Leuprolide acetate: a drug of diverse clinical applications","volume":"16","author":"Wilson","year":"2007","journal-title":"Expert Opin Investig Drugs"},{"key":"10.1111\/j.1745-7262.2008.00409.x-BIB4","doi-asserted-by":"crossref","first-page":"287","DOI":"10.2165\/00024677-200605050-00003","article-title":"Gonadotropin-releasing hormone analog therapy for central precocious puberty and other childhood disorders affecting growth and puberty","volume":"5","author":"Lee","year":"2006","journal-title":"Treat Endocrinol"},{"key":"10.1111\/j.1745-7262.2008.00409.x-BIB5","first-page":"104","volume-title":"Precocious Sexual Development, a Clinical Study of 100 Children","author":"Thamdrup","year":"1961"},{"key":"10.1111\/j.1745-7262.2008.00409.x-BIB6","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1136\/adc.70.2.116","article-title":"Sexual precocity: sex incidence and aetiology","volume":"70","author":"Bridges","year":"1994","journal-title":"Arch Dis Child"},{"issue":"Suppl 1","key":"10.1111\/j.1745-7262.2008.00409.x-BIB7","first-page":"695","article-title":"Etiology and age incidence of precocious puberty in girls: a multicentric study","volume":"13","author":"Cisternino","year":"2000","journal-title":"J Pediatr Endocrinol Metab"},{"issue":"Suppl 1","key":"10.1111\/j.1745-7262.2008.00409.x-BIB8","first-page":"687","article-title":"Etiology of central precocious puberty in males: the results of the Italian Study Group for Physiopathology of Puberty","volume":"13","author":"De Sanctis","year":"2000","journal-title":"J Pediatr Endocrinol Metab"},{"key":"10.1111\/j.1745-7262.2008.00409.x-BIB9","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1046\/j.1365-2265.2001.01229.x","article-title":"Central precocious puberty: clinical and laboratory features","volume":"54","author":"Chemaitilly","year":"2001","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.1111\/j.1745-7262.2008.00409.x-BIB10","doi-asserted-by":"crossref","first-page":"4711","DOI":"10.1210\/jcem.86.10.7915","article-title":"Increased final height in precocious puberty after long-term treatment with LHRH agonists: the National Institutes of Health experience","volume":"86","author":"Klein","year":"2001","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1111\/j.1745-7262.2008.00409.x-BIB11","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1001\/archpedi.1968.02100010311003","article-title":"Precocious puberty. A report of 96 cases","volume":"115","author":"Sigurjonsdottir","year":"1968","journal-title":"Am J Dis Child"},{"key":"10.1111\/j.1745-7262.2008.00409.x-BIB12","first-page":"587","article-title":"Aspects tiologiques, cliniques et biologiques des pubertes precoces d'origine centrale","volume":"27","author":"Bovier-Lapierre","year":"1972","journal-title":"Pediatrie"},{"key":"10.1111\/j.1745-7262.2008.00409.x-BIB13","first-page":"546","article-title":"Long-term effect of gonadotropin releasing hormone agonist therapy on final and near-final height in 26 children with true precocious puberty treated at a median age of less than 5 years","volume":"80","author":"Paul","year":"1995","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1111\/j.1745-7262.2008.00409.x-BIB14","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1136\/adc.51.3.170","article-title":"Clinical longitudianl standards for height, weight, height velocity, weight velocity and stages of puberty","volume":"51","author":"Tanner","year":"1976","journal-title":"Arch Dis Child"},{"key":"10.1111\/j.1745-7262.2008.00409.x-BIB15","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1093\/humupd\/dmh012","article-title":"Precocious puberty and statural growth","volume":"10","author":"Carel","year":"2004","journal-title":"Hum Reprod Update"},{"key":"10.1111\/j.1745-7262.2008.00409.x-BIB16","first-page":"1","article-title":"Effect of gonadotropin-releasing hormone agonist treatment in boys with central precocious puberty","volume":"58","author":"Mul","year":"2002","journal-title":"Horm Res"},{"key":"10.1111\/j.1745-7262.2008.00409.x-BIB17","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1111\/j.1552-6909.2007.00145.x","article-title":"Precocious puberty: a comprehensive review of literature","volume":"36","author":"Cesario","year":"2007","journal-title":"J Obstet Gynecol Neonatal Nurs"},{"key":"10.1111\/j.1745-7262.2008.00409.x-BIB18","doi-asserted-by":"crossref","first-page":"340","DOI":"10.3171\/jns.1998.88.2.0340","article-title":"Role of surgical resection in the treatment of hypothalamic hamartomas causing precocious puberty. Report of six cases","volume":"88","author":"Stewart","year":"1998","journal-title":"J Neurosurgur"},{"key":"10.1111\/j.1745-7262.2008.00409.x-BIB19","doi-asserted-by":"crossref","first-page":"4036","DOI":"10.1210\/jcem.85.11.6951","article-title":"Boys with precocious puberty due to hypothalamic hamartoma: reproductive axis after discontinuation of gonadotropin-releasing hormone analog therapy","volume":"85","author":"Feuillan","year":"2000","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1111\/j.1745-7262.2008.00409.x-BIB20","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1210\/jcem.84.1.5409","article-title":"Reproductive axis after discontinuation of gonadotropin-releasing hormone analog treatment of girls with precocious puberty: long term follow-up comparing girls with hypothalamic hamartoma to those with idiopathic precocious puberty","volume":"84","author":"Feuillan","year":"1999","journal-title":"J Clin Endocrinol Metab"},{"issue":"Suppl 1","key":"10.1111\/j.1745-7262.2008.00409.x-BIB21","first-page":"723","article-title":"Pharmacokinetics and pharmacodynamics of GnRH agonists: clinical implications in pediatrics","volume":"13","author":"Lahlou","year":"2000","journal-title":"J Pediatr Endocrinol Metab"},{"issue":"Suppl 1","key":"10.1111\/j.1745-7262.2008.00409.x-BIB22","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1515\/JPEM.2000.13.S1.765","article-title":"Final height after gonadotrophin releasing hormone agonist treatment for central precocious puberty: the Dutch experience","volume":"13","author":"Mul","year":"2000","journal-title":"J Pediatr Endocrinol Metab"},{"key":"10.1111\/j.1745-7262.2008.00409.x-BIB23","doi-asserted-by":"crossref","first-page":"1973","DOI":"10.1210\/jcem.84.6.5647","article-title":"Final height after long-term treatment with Triptorelin slow release for central precocious puberty: Importance of statural growth after interruption of treatment","volume":"84","author":"Carel","year":"1999","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1111\/j.1745-7262.2008.00409.x-BIB24","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1111\/j.1651-2227.1998.tb01497.x","article-title":"Adult height comparison between boys and girls with precocious puberty after long-term gonadotrophin-releasing hormone analogue therapy","volume":"87","author":"Galluzzi","year":"1998","journal-title":"Acta Paediatrica"},{"key":"10.1111\/j.1745-7262.2008.00409.x-BIB25","first-page":"4583","article-title":"Long-term outcome after depot gonadotropin-releasing hormone agonist treatment of central precocious puberty: final height, body proportions, body composition, bone mineral density, and reproductive function","volume":"84","author":"Heger","year":"1999","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1111\/j.1745-7262.2008.00409.x-BIB26","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1046\/j.1365-2265.2002.01488.x","article-title":"Factors predicting adult height in girls with central precocious puberty: implications for treatment","volume":"56","author":"Adan","year":"2002","journal-title":"Clin Endocrinol"},{"key":"10.1111\/j.1745-7262.2008.00409.x-BIB27","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1007\/s004310051289","article-title":"Final height, gonadal function and bone mineral density of adolescent males with central precocious puberty after therapy with gonadotropin-releasing hormone analogues","volume":"159","author":"Bertelloni","year":"2000","journal-title":"Eur J Pediatr"},{"key":"10.1111\/j.1745-7262.2008.00409.x-BIB28","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1210\/jc.2007-1216","article-title":"Long-term observation of 87 girls with idiopathic central precocious puberty treated with GnRH analogues: impact on adult height, body mass index, bone mineral content and reproductive function","volume":"93","author":"Pasquino","year":"2008","journal-title":"J Clin Endocrinol Metab"},{"issue":"Suppl 1","key":"10.1111\/j.1745-7262.2008.00409.x-BIB29","first-page":"781","article-title":"Factors influencing final\/near-final height in 12 boys with central precocious puberty treated with gonadotrophin-releasing hormone agonists. Italian Study Group of Physiopathology of Puberty","volume":"13","author":"Rizzo","year":"2000","journal-title":"J Pediatr Endocrinol Metab"},{"key":"10.1111\/j.1745-7262.2008.00409.x-BIB30","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1530\/eje.0.1320699","article-title":"Treatment of central precocious puberty with depot leuprorelin. French Leuprorelin Trial Group","volume":"132","author":"Carel","year":"1995","journal-title":"Eur J Endocrinol"},{"key":"10.1111\/j.1745-7262.2008.00409.x-BIB31","first-page":"653","article-title":"Long-term effectiveness of depot gonadotropin-releasing hormone analogue in the treatment of children with central precocious puberty","volume":"147","author":"Clemons","year":"1993","journal-title":"Am J Dis Child"},{"key":"10.1111\/j.1745-7262.2008.00409.x-BIB32","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1016\/S0022-3476(05)81162-X","article-title":"Two-year results of treatment with depot leuprolide acetate for central precocious puberty","volume":"121","author":"Neely","year":"1992","journal-title":"J Pediatr"},{"key":"10.1111\/j.1745-7262.2008.00409.x-BIB33","first-page":"369","article-title":"A dose finding study of a super long-acting luteinizing hormone-releasing hormone analog (leuprolide acetate depot, TAP-144-SR) in the treatment of central precocious puberty. The TAP-144-SR CPP Study Group","volume":"38","author":"Tanaka","year":"1991","journal-title":"Endocrinology"},{"key":"10.1111\/j.1745-7262.2008.00409.x-BIB34","doi-asserted-by":"crossref","first-page":"1371","DOI":"10.1210\/jc.2004-1863","article-title":"Results of long-term follow-up after treatment of central precocious puberty with leuprorelin acetate: evaluation of effectiveness of treatment and recovery of gonadal function. The TAP-144-SR Japanese Study Group on Central Precocious Puberty","volume":"90","author":"Tanaka","year":"2005","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1111\/j.1745-7262.2008.00409.x-BIB35","first-page":"1206","article-title":"Assessment of depot leuprolide acetate dose-adequacy for central precocious puberty","volume":"74","author":"Cook","year":"1992","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1111\/j.1745-7262.2008.00409.x-BIB36","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1136\/adc.79.4.323","article-title":"Efficacy of Zoladex LA (goserelin) in the treatment of girls with central precocious or early puberty","volume":"79","author":"Paterson","year":"1998","journal-title":"Arch Dis Child"},{"key":"10.1111\/j.1745-7262.2008.00409.x-BIB37","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1136\/adc.80.3.231","article-title":"Treatment of gonadotropin dependent precocious puberty due to hypothalamic hamartoma with gonadotropin releasing hormone agonist depot","volume":"80","author":"de Brito","year":"1999","journal-title":"Arch Dis Child"},{"key":"10.1111\/j.1745-7262.2008.00409.x-BIB38","doi-asserted-by":"crossref","first-page":"4111","DOI":"10.1210\/jc.2001-020243","article-title":"Treatment of central precocious puberty by subcutaneous injections of leuprorelin 3-month depot (11.25 mg)","volume":"87","author":"Carel","year":"2002","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1111\/j.1745-7262.2008.00409.x-BIB39","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1046\/j.1365-2265.2002.01571.x","article-title":"Suppression of puberty with long-acting goserelin (Zoladex-LA): effect on gonadotrophin response to GnRH in the first treatment cycle","volume":"57","author":"Trueman","year":"2002","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.1111\/j.1745-7262.2008.00409.x-BIB40","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1111\/j.1365-2265.2004.02146.x","article-title":"Auxological outcome and time to menarche following long-acting goserelin therapy in girls with central precocious or early puberty","volume":"61","author":"Paterson","year":"2004","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.1111\/j.1745-7262.2008.00409.x-BIB41","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1515\/JPEM.2006.19.8.963","article-title":"Treatment of central precocious puberty with triptorelin 11.25 mg depot formulation","volume":"19","author":"Mart\u00ednez-Aguayo","year":"2006","journal-title":"J Pediatr Endocrinol Metab"},{"issue":"Suppl 2","key":"10.1111\/j.1745-7262.2008.00409.x-BIB42","first-page":"297","article-title":"Central precocious puberty: short-term comparative data of treatment with montly or long-acting three months depot triptorelin","volume":"20","author":"Bertelloni","year":"2007","journal-title":"J Pediatr Endocrinol Metab"},{"key":"10.1111\/j.1745-7262.2008.00409.x-BIB43","doi-asserted-by":"crossref","first-page":"1697","DOI":"10.1210\/jc.2006-2479","article-title":"Efficacy and safety of histrelin subdermal implant in children with central precocious puberty: a multicenter trial","volume":"92","author":"Eugster","year":"2007","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1111\/j.1745-7262.2008.00409.x-BIB44","doi-asserted-by":"crossref","first-page":"4127","DOI":"10.1210\/jcem.86.9.7852","article-title":"Sexual precocity in boys: Accelerated versus slowly progressive puberty gonadotropin-suppressive therapy and final height","volume":"86","author":"Lazar","year":"2001","journal-title":"J Clin Endocrinol Metab"},{"issue":"Suppl 1","key":"10.1111\/j.1745-7262.2008.00409.x-BIB45","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1515\/JPEM.2000.13.S1.765","article-title":"Final height after gonadotrophin releasing hormone agonist treatment for central precocious puberty: the Dutch experience","volume":"13","author":"Mul","year":"2000","journal-title":"J Pediatr Endocrinol Metab"},{"key":"10.1111\/j.1745-7262.2008.00409.x-BIB46","first-page":"633","article-title":"Long-acting GnRH analogue triptorelin therapy in central isosexual precocious puberty","volume":"39","author":"Bajpai","year":"2002","journal-title":"Indian Pediatr"},{"key":"10.1111\/j.1745-7262.2008.00409.x-BIB47","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1159\/000185432","article-title":"Final height of girls with central precocious puberty, untreated versus treated with cyproterone acetate or GnRH analogue. A comparative study with re-evaluation of predictions by the Bayley-Pinneau method","volume":"47","author":"Kauli","year":"1997","journal-title":"Horm Res"},{"issue":"Suppl 2","key":"10.1111\/j.1745-7262.2008.00409.x-BIB48","first-page":"285","article-title":"Growth and pubertal disorders in Neurofibromatosis type 1","volume":"16","author":"Virdis","year":"2003","journal-title":"J Pediatr Endocrinol Metab"},{"key":"10.1111\/j.1745-7262.2008.00409.x-BIB49","first-page":"415","article-title":"Unsustained or slowly progressive puberty in young girls: initial presentation and long-term follow-up of 20 untreated patients","volume":"84","author":"Palmert","year":"1999","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1111\/j.1745-7262.2008.00409.x-BIB50","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1067\/mpd.2000.109201","article-title":"Do all girls with apparent idiopathic precocious puberty require gonadotropin-releasing hormone agonist treatment","volume":"137","author":"Leger","year":"2000","journal-title":"J Pediatr"},{"key":"10.1111\/j.1745-7262.2008.00409.x-BIB51","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1007\/s004310050831","article-title":"Effect of central precocious puberty and gonadotropin-releasing hormone analogue treatment on peak bone mass and final height in females","volume":"157","author":"Bertelloni","year":"1998","journal-title":"Eur J Pediatr"},{"key":"10.1111\/j.1745-7262.2008.00409.x-BIB52","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1530\/eje.0.1410140","article-title":"Analysis of the factors affecting auxological response to GnRH agonist treatment and final height outcome in girls with idiopathic central precocious puberty","volume":"141","author":"Arrigo","year":"1999","journal-title":"Eur J Endocrinol"},{"key":"10.1111\/j.1745-7262.2008.00409.x-BIB53","doi-asserted-by":"crossref","first-page":"3668","DOI":"10.1210\/jcem-67-2-368","article-title":"Resumption of puberty after long term luteinizing hormone-releasing hormone agonist treatment of central precocious puberty","volume":"67","author":"Manasco","year":"1988","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1111\/j.1745-7262.2008.00409.x-BIB54","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1080\/00365590600589641","article-title":"Prevalence of testicular microlithiasis in an asymptomatic population","volume":"40","author":"Serter","year":"2006","journal-title":"Scand J Urol Nephrol"},{"key":"10.1111\/j.1745-7262.2008.00409.x-BIB55","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1038\/ncpuro0856","article-title":"Current management strategies for testicular microlithiasis","volume":"4","author":"Jaganathan","year":"2007","journal-title":"Nat Clin Pract Urol"},{"key":"10.1111\/j.1745-7262.2008.00409.x-BIB56","doi-asserted-by":"crossref","first-page":"1904","DOI":"10.1097\/01.ju.0000142449.47356.29","article-title":"Testicular microlithiasis and its relation to testicular cancer on ultrasound findings of symptomatic men","volume":"172","author":"Ringdahl","year":"2004","journal-title":"J Urol"},{"issue":"Suppl 1","key":"10.1111\/j.1745-7262.2008.00409.x-BIB57","first-page":"791","article-title":"Precocious puberty and body composition: effects of GnRH analog treatment","volume":"13","author":"Chiumello","year":"2000","journal-title":"J Pediatr Endocrinol Metab"},{"key":"10.1111\/j.1745-7262.2008.00409.x-BIB58","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1530\/eje.1.01975","article-title":"Outcome after depot gonadotrophin-releasing hormone agonist treatment for central precocious puberty: effects on body mass index and final height","volume":"153","author":"Traggiai","year":"2005","journal-title":"Eur J Endocrinol"},{"key":"10.1111\/j.1745-7262.2008.00409.x-BIB59","first-page":"4480","article-title":"Is obesity an outcome of gonadotropin-releasing hormone agonist administration? Analysis of growth and body composition in 110 patients with central precocious puberty","volume":"84","author":"Palmert","year":"1999","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1111\/j.1745-7262.2008.00409.x-BIB60","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1530\/eje.0.1500533","article-title":"Reduction of baseline body mass index under gonadotropin-suppressive therapy in girls with idiopathic precocious puberty","volume":"150","author":"Arrigo","year":"2004","journal-title":"Eur J Endocrinol"},{"key":"10.1111\/j.1745-7262.2008.00409.x-BIB61","unstructured":"61 Chiocca E , Dati E , Bertelloni S. Bone mass and body composition in adolescent girls treated by gonadotrophin releasing hormone analogue for central precocious puberty. 9th International Symposium on GnRH: \u201cThe hypothalamic-pituitary-gonadal axis in cancer and reproduction\u201d, Berlin, 1012 February 2008."},{"key":"10.1111\/j.1745-7262.2008.00409.x-BIB62","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1210\/jcem.87.2.8202","article-title":"Longitudinal follow-up of bone density and body composition in children with precocious or early puberty before, during and after cessation of GnRH agonist therapy","volume":"87","author":"van der Sluis","year":"2002","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1111\/j.1745-7262.2008.00409.x-BIB63","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1530\/eje.0.1330412","article-title":"Bone mineral metabolism in girls with precocious puberty during gonadotrophin-releasing hormone agonist treatment","volume":"133","author":"Antoniazzi","year":"1995","journal-title":"Eur J Endocrinol"},{"key":"10.1111\/j.1745-7262.2008.00409.x-BIB64","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1016\/S0929-6646(08)60047-9","article-title":"The effects of gonadotropin releasing hormone analogue therapy on girls with gonadotropin-dependent precocious puberty","volume":"106","author":"Tung","year":"2007","journal-title":"J Formos Med Assoc"}],"container-title":["Asian Journal of Andrology"],"original-title":[],"language":"en","deposited":{"date-parts":[[2019,2,12]],"date-time":"2019-02-12T06:31:41Z","timestamp":1549953101000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.asiaandro.com\/Abstract.asp?doi=10.1111\/j.1745-7262.2008.00409.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,7]]},"references-count":64,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2008,7]]}},"URL":"https:\/\/doi.org\/10.1111\/j.1745-7262.2008.00409.x","relation":{},"ISSN":["1008-682X","1745-7262"],"issn-type":[{"value":"1008-682X","type":"print"},{"value":"1745-7262","type":"electronic"}],"subject":[],"published":{"date-parts":[[2008,7]]}}}